Breast cancer, screening and diagnostic tools: All you need to know

D Barba, A León-Sosa, P Lugo, D Suquillo… - Critical reviews in …, 2021 - Elsevier
Breast cancer is one of the most frequent malignancies among women worldwide. Methods
for screening and diagnosis allow health care professionals to provide personalized …

[HTML][HTML] Inflammation, immunosuppressive microenvironment and breast cancer: opportunities for cancer prevention and therapy

SK Deshmukh, SK Srivastava, T Poosarla… - Annals of …, 2019 - ncbi.nlm.nih.gov
Breast cancer is the most commonly diagnosed malignancy and a leading cause of cancer-
related death in women worldwide. It also exhibits pronounced racial disparities in terms of …

Network-based assessment of HDAC6 activity predicts preclinical and clinical responses to the HDAC6 inhibitor ricolinostat in breast cancer

TZ Zeleke, Q Pan, C Chiuzan, M Onishi, Y Li, H Tan… - Nature cancer, 2023 - nature.com
Inhibiting individual histone deacetylase (HDAC) is emerging as well-tolerated anticancer
strategy compared with pan-HDAC inhibitors. Through preclinical studies, we demonstrated …

Estrogen Receptor Downregulates Expression of PD-1/PD-L1 and Infiltration of CD8+ T Cells by Inhibiting IL-17 Signaling Transduction in Breast Cancer

C Shuai, X Yang, H Pan, W Han - Frontiers in Oncology, 2020 - frontiersin.org
Background: The relationship between the interleukin 17 (IL-17) family of cytokines and
breast cancer has been widely studied in recent years. Many studies have revealed …

Evaluation of breast edema findings at T2-weighted breast MRI is useful for diagnosing occult inflammatory breast cancer and can predict prognosis after neoadjuvant …

TL Harada, T Uematsu, K Nakashima, T Kawabata… - Radiology, 2021 - pubs.rsna.org
Background Prediction of occult inflammatory breast cancer (IBC) and breast cancer
prognosis based on breast edema findings on T2-weighted MRI scans, even for patients …

The interleukin-17 family of cytokines in breast cancer

JAS Fabre, J Giustiniani, C Garbar… - International journal of …, 2018 - mdpi.com
Breast cancer (BC) is the most common cancer in women worldwide and remains a major
cause of mortality with an expected 137,000 death this year in Europe. Standard …

Comprehensive genomic profiling of inflammatory breast cancer cases reveals a high frequency of clinically relevant genomic alterations

JS Ross, SM Ali, K Wang, D Khaira, NA Palma… - Breast cancer research …, 2015 - Springer
Inflammatory breast cancer (IBC) is a distinct clinicopathologic entity that carries a worse
prognosis relative to non-IBC breast cancer even when matched for standard biomarkers …

Incidence and survival of inflammatory breast cancer between 1973 and 2015 in the SEER database

HG Abraham, Y Xia, B Mukherjee… - Breast Cancer Research …, 2021 - Springer
Purpose Inflammatory breast cancer (IBC) is an aggressive variant characterized by
erythema, edema, and “peau d'orange” of the skin progressing within 6 months. We …

Skin diseases of the breast and nipple: benign and malignant tumors

RA Waldman, J Finch, JM Grant-Kels… - Journal of the American …, 2019 - Elsevier
The evaluation and management of dermatologic diseases of the breast and nipple requires
an understanding of the unique anatomy of the breast and nipple and an awareness of the …

Gold Nanoparticles Doped with 199Au Atoms and Their Use for Targeted Cancer Imaging by SPECT

Y Zhao, B Pang, H Luehmann… - Advanced …, 2016 - Wiley Online Library
Gold nanoparticles have been labeled with various radionuclides and extensively explored
for single photon emission computed tomography (SPECT) in the context of cancer …